Effectiveness of Intracavernous Delivery of Recombinant Human Hepatocyte Growth Factor on Erectile Function in the Streptozotocin-Induced Diabetic Mouse

J Sex Med. 2016 Nov;13(11):1618-1628. doi: 10.1016/j.jsxm.2016.09.017.

Abstract

Introduction: Diabetic erectile dysfunction is a disease mostly of vascular origin and men with diabetic erectile dysfunction respond poorly to oral phosphodiesterase-5 inhibitors. Hepatocyte growth factor (HGF) is a pleiotropic factor that plays an essential role in the regulation of cell proliferation, survival, and angiogenesis.

Aim: To determine the effectiveness of recombinant human (rh)-HGF in restoring erectile function in diabetic mice.

Methods: Four groups of mice were used: control non-diabetic mice and streptozotocin-induced diabetic mice receiving two successive intracavernous injections of phosphate buffered saline (days -3 and 0), a single intracavernous injection of rh-HGF (day 0), or two successive intracavernous injections of rh-HGF (days -3 and 0). We also examined the effect of rh-HGF in primary cultured mouse cavernous endothelial cells and in major pelvic ganglion culture in vitro, which was incubated under a normal-glucose (5 mmol/L) or a high-glucose (30 mmol/L) condition.

Main outcome measures: Two weeks after treatment, we measured erectile function by electrical stimulation of the cavernous nerve and the penis was harvested for histologic studies.

Results: Repeated intracavernous injections of rh-HGF protein induced significant restoration of erectile function in diabetic mice (89-100% of control values), whereas a single intracavernous injection of rh-HGF protein elicited modest improvement. Rh-HGF significantly induced phosphorylation of its receptor c-Met, increased the content of endothelial cells and smooth muscle cells, and decreased the generation of reactive oxygen species (superoxide anion and peroxynitrite) and extravasation of oxidized low-density lipoprotein in diabetic mice. Under the high-glucose condition, rh-HGF protein also promoted tube formation in mouse cavernous endothelial cells and enhanced neurite sprouting in major pelvic ganglion culture in vitro.

Conclusion: The dual angiogenic and neurotrophic effects of HGF could open a new avenue through which diabetic erectile dysfunction can be treated.

Keywords: Angiogenesis; Diabetes Mellitus; Erectile Dysfunction; Hepatocyte Growth Factor; Neural Regeneration.

MeSH terms

  • Animals
  • Cell Proliferation / physiology
  • Diabetes Mellitus, Experimental / physiopathology
  • Endothelial Cells / cytology
  • Endothelial Cells / physiology
  • Endothelium / metabolism
  • Erectile Dysfunction / drug therapy*
  • Erectile Dysfunction / physiopathology
  • Hepatocyte Growth Factor / pharmacology*
  • Humans
  • Injections, Intralesional
  • Lipoproteins, LDL / metabolism
  • Male
  • Mice, Inbred C57BL
  • Nitric Oxide Synthase Type III / metabolism
  • Penile Erection / drug effects*
  • Penis / blood supply
  • Phosphodiesterase 5 Inhibitors / pharmacology
  • Phosphorylation / physiology
  • Rats, Sprague-Dawley
  • Recombinant Proteins / pharmacology
  • Regeneration / physiology

Substances

  • Lipoproteins, LDL
  • Phosphodiesterase 5 Inhibitors
  • Recombinant Proteins
  • oxidized low density lipoprotein
  • Hepatocyte Growth Factor
  • Nitric Oxide Synthase Type III